Standard BioTools Retained Earnings (Accumulated Deficit) 2010-2025 | LAB
Standard BioTools retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Standard BioTools Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-1,186 |
| 2023 | $-1,001 |
| 2022 | $-926 |
| 2021 | $-736 |
| 2020 | $-677 |
| 2019 | $-624 |
| 2018 | $-559 |
| 2017 | $-500 |
| 2016 | $-439 |
| 2015 | $-363 |
| 2014 | $-310 |
| 2013 | $-257 |
| 2012 | $-241 |
| 2011 | $-222 |
| 2010 | $-199 |
| 2009 | $-182 |
| Standard BioTools Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-1,212 |
| 2024-12-31 | $-1,186 |
| 2024-09-30 | $-1,152 |
| 2024-06-30 | $-1,125 |
| 2024-03-31 | $-1,079 |
| 2023-12-31 | $-1,001 |
| 2023-09-30 | $-981 |
| 2023-06-30 | $-960 |
| 2023-03-31 | $-943 |
| 2022-12-31 | $-926 |
| 2022-09-30 | $-905 |
| 2022-06-30 | $-876 |
| 2022-03-31 | $-812 |
| 2021-12-31 | $-736 |
| 2021-09-30 | $-727 |
| 2021-06-30 | $-713 |
| 2021-03-31 | $-696 |
| 2020-12-31 | $-677 |
| 2020-09-30 | $-659 |
| 2020-06-30 | $-653 |
| 2020-03-31 | $-640 |
| 2019-12-31 | $-624 |
| 2019-09-30 | $-611 |
| 2019-06-30 | $-598 |
| 2019-03-31 | $-584 |
| 2018-12-31 | $-559 |
| 2018-09-30 | $-544 |
| 2018-06-30 | $-529 |
| 2018-03-31 | $-513 |
| 2017-12-31 | $-500 |
| 2017-09-30 | $-490 |
| 2017-06-30 | $-474 |
| 2017-03-31 | $-457 |
| 2016-12-31 | $-439 |
| 2016-09-30 | $-422 |
| 2016-06-30 | $-402 |
| 2016-03-31 | $-383 |
| 2015-12-31 | $-363 |
| 2015-09-30 | $-351 |
| 2015-06-30 | $-341 |
| 2015-03-31 | $-326 |
| 2014-12-31 | $-310 |
| 2014-09-30 | $-299 |
| 2014-06-30 | $-285 |
| 2014-03-31 | $-273 |
| 2013-12-31 | $-257 |
| 2013-09-30 | $-253 |
| 2013-06-30 | $-248 |
| 2013-03-31 | $-244 |
| 2012-12-31 | $-241 |
| 2012-09-30 | $-237 |
| 2012-06-30 | $-233 |
| 2012-03-31 | $-228 |
| 2011-12-31 | $-222 |
| 2011-09-30 | $-218 |
| 2011-06-30 | $-214 |
| 2011-03-31 | $-207 |
| 2010-12-31 | $-199 |
| 2010-09-30 | $-196 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.384B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.506B | 58.15 |
| Hims & Hers Health (HIMS) | United States | $12.660B | 131.54 |
| Tempus AI (TEM) | United States | $9.553B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.486B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.076B | 63.69 |
| Hinge Health (HNGE) | United States | $3.030B | 0.00 |
| Privia Health (PRVA) | United States | $2.775B | 189.67 |
| Enovis (ENOV) | United States | $1.788B | 9.97 |
| Clover Health Investments (CLOV) | United States | $1.598B | 0.00 |
| Schrodinger (SDGR) | United States | $1.586B | 0.00 |
| Phreesia (PHR) | United States | $1.457B | 0.00 |
| Omnicell (OMCL) | United States | $1.423B | 25.10 |
| Azenta (AZTA) | United States | $1.223B | 56.85 |
| 10x Genomics (TXG) | United States | $1.173B | 0.00 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.593B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 159.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| TruBridge (TBRG) | United States | $0.360B | 797.67 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |